Compare AJANTA PHARMA with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA TORRENT PHARMA AJANTA PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 24.7 35.1 70.3% View Chart
P/BV x 6.9 8.9 77.1% View Chart
Dividend Yield % 0.5 0.7 75.1%  

Financials

 AJANTA PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
TORRENT PHARMA
Mar-19
AJANTA PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,4221,964 72.4%   
Low Rs8981,245 72.1%   
Sales per share (Unadj.) Rs233.5453.4 51.5%  
Earnings per share (Unadj.) Rs44.025.8 170.5%  
Cash flow per share (Unadj.) Rs52.262.3 83.7%  
Dividends per share (Unadj.) Rs9.0017.00 52.9%  
Dividend yield (eoy) %0.81.1 73.2%  
Book value per share (Unadj.) Rs255.1279.2 91.4%  
Shares outstanding (eoy) m88.02169.22 52.0%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.03.5 140.4%   
Avg P/E ratio x26.462.2 42.4%  
P/CF ratio (eoy) x22.225.8 86.3%  
Price / Book Value ratio x4.55.7 79.1%  
Dividend payout %20.565.9 31.0%   
Avg Mkt Cap Rs m102,081271,513 37.6%   
No. of employees `0006.813.6 50.0%   
Total wages/salary Rs m4,30714,038 30.7%   
Avg. sales/employee Rs Th3,022.65,642.6 53.6%   
Avg. wages/employee Rs Th633.41,032.4 61.4%   
Avg. net profit/employee Rs Th569.1320.9 177.4%   
INCOME DATA
Net Sales Rs m20,55476,728 26.8%  
Other income Rs m211571 37.0%   
Total revenues Rs m20,76577,299 26.9%   
Gross profit Rs m5,66419,831 28.6%  
Depreciation Rs m7216,177 11.7%   
Interest Rs m125,038 0.2%   
Profit before tax Rs m5,1439,187 56.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,570 0.0%   
Tax Rs m1,2731,254 101.6%   
Profit after tax Rs m3,8704,363 88.7%  
Gross profit margin %27.625.8 106.6%  
Effective tax rate %24.813.6 181.4%   
Net profit margin %18.85.7 331.1%  
BALANCE SHEET DATA
Current assets Rs m11,81250,375 23.4%   
Current liabilities Rs m3,77651,653 7.3%   
Net working cap to sales %39.1-1.7 -2,347.7%  
Current ratio x3.11.0 320.7%  
Inventory Days Days7792 84.1%  
Debtors Days Days8268 119.5%  
Net fixed assets Rs m14,39883,648 17.2%   
Share capital Rs m175846 20.7%   
"Free" reserves Rs m22,27746,397 48.0%   
Net worth Rs m22,45247,244 47.5%   
Long term debt Rs m739,129 0.0%   
Total assets Rs m26,962141,209 19.1%  
Interest coverage x444.32.8 15,736.2%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x0.80.5 140.3%   
Return on assets %14.46.7 216.2%  
Return on equity %17.29.2 186.6%  
Return on capital %23.012.3 186.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,68222,103 48.3%   
Fx outflow Rs m2,1025,522 38.1%   
Net fx Rs m8,58016,581 51.7%   
CASH FLOW
From Operations Rs m3,74817,981 20.8%  
From Investments Rs m-2,228-2,413 92.3%  
From Financial Activity Rs m-1,475-13,145 11.2%  
Net Cashflow Rs m452,380 1.9%  

Share Holding

Indian Promoters % 73.8 71.5 103.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 7.0 22.1%  
FIIs % 7.6 12.6 60.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 8.8 193.2%  
Shareholders   20,968 26,511 79.1%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SANOFI INDIA  ABBOTT INDIA  STRIDES PHARMA SCIENCE  CIPLA  ASTRAZENECA PHARMA  

Compare AJANTA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Mar 5, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - DR. DATSONS LABS COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS